A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid Tumors

Condition:   Refractory Solid Tumors Interventions:   Drug: Eribulin;   Drug: Irinotecan;   Drug: Temozolomide Sponsor:   M.D. Anderson Cancer Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials